X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-16 | NUVB | Nuvation Bio Inc. | Hung David | Pres, CEO, 10% | P - Purchase | $1.79 | +500,000 | 59,281,054 | +1% | +$893,500 | ||||||
2025-06-20 | CAI | Caris Life Sciences, Inc. | Brille Brian J | See Remarks | P - Purchase | $21.00 | +30,000 | 662,428 | +5% | +$630,000 | ||||||
2025-06-20 | THAR | Tharimmune, Inc. | Gravitas Capital LP | Exec COB, 10% | P - Purchase | $1.48 | +337,838 | 732,424 | +86% | +$500,000 | ||||||
2025-06-17 | GIII | G III Apparel Group Ltd /De/ | Goldfarb Jeffrey David | EVP | P - Purchase | $21.33 | +23,076 | 661,398 | +4% | +$492,211 | ||||||
2025-06-18 | OXM | Oxford Industries Inc | Trauber Robert S. | CEO, Johnny Was | P - Purchase | $41.38 | +10,000 | 13,364 | +297% | +$413,750 | ||||||
| D | 2025-06-20 | DOMO | Domo, Inc. | James Joshua G | Founder, CEO, 10% | P - Purchase | $12.74 | +13,025 | 1,638,525 | +1% | +$165,897 | |||||
| D | 2025-06-20 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | P - Purchase | $21.00 | +7,500 | 128,591 | +6% | +$157,500 | |||||
2025-06-20 | THAR | Tharimmune, Inc. | Appajosyula Sireesh | CEO | P - Purchase | $1.48 | +61,496 | 64,868 | >999% | +$90,973 | ||||||
2025-06-16 | NUVB | Nuvation Bio Inc. | Sjogren Colleen | Chief Commercial Officer | P - Purchase | $1.81 | +50,000 | 81,000 | +161% | +$90,350 | ||||||
2025-06-16 | NUVB | Nuvation Bio Inc. | Wentworth Kerry | Chief Regulatory Officer | P - Purchase | $1.79 | +50,000 | 50,000 | New | +$89,740 | ||||||
2025-06-17 | CIA | Citizens, Inc. | Stenberg Jon | Pres, CEO | P - Purchase | $3.33 | +19,914 | 328,143 | +6% | +$66,407 | ||||||
2025-06-18 | DLTR | Dollar Tree, Inc. | Maheshwari Aditya | Chief Accounting Officer | P - Purchase | $98.20 | +610 | 4,841 | +14% | +$59,899 | ||||||
2025-06-18 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres, CEO, 10% | P - Purchase | $2.39 | +21,000 | 3,197,779 | +1% | +$50,144 | ||||||
2025-06-20 | MTN | Vail Resorts Inc | Korch Angela A | EVP, CFO | P - Purchase | $157.00 | +200 | 3,156 | +7% | +$31,400 | ||||||
2025-06-16 | DLTH | Duluth Holdings Inc. | Agrawal Heena | SVP, CFO | P - Purchase | $1.90 | +13,000 | 238,093 | +6% | +$24,657 | ||||||
2025-06-17 | GRF | Eagle Capital Growth Fund, Inc. | Sims Luke E | Pres, CEO | P - Purchase | $9.80 | +2,100 | 297,774 | +1% | +$20,580 | ||||||
2025-06-17 | AKTX | Akari Therapeutics Plc | Gaslightwala Abizer | Pres, CEO | P - Purchase | $1.20 | +15,000 | 261,428 | +6% | +$18,000 | ||||||
2025-06-18 | NUVB | Nuvation Bio Inc. | Markel Stacy | Chief People Officer | P - Purchase | $1.71 | +10,000 | 29,591 | +51% | +$17,100 | ||||||
2025-06-17 | MKTW | Marketwise, Inc. | Mickels Erik | CFO | P - Purchase | $17.94 | +940 | 69,998 | +1% | +$16,864 | ||||||
2025-06-13 | GLBZ | Glen Burnie Bancorp | Hanna Mark Christopher | Pres, CEO | P - Purchase | $4.76 | +3,000 | 16,570 | +22% | +$14,280 | ||||||
| M | 2025-06-16 | NUVB | Nuvation Bio Inc. | Sauvage Philippe | CFO | P - Purchase | $1.81 | +7,300 | 9,902 | +281% | +$13,216 | |||||
2025-06-18 | LAKE | Lakeland Industries Inc | Jenkins James M. | Pres, CEO, Exec. Chair | P - Purchase | $13.14 | +1,000 | 98,262 | +1% | +$13,140 | ||||||
2025-06-17 | CRMT | Americas Carmart Inc | Collins Jonathan M. | CFO | P - Purchase | $49.30 | +102 | 6,247 | +2% | +$5,029 | ||||||
2025-06-18 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | CEO | P - Purchase | $1.14 | +4,350 | 344,120 | +1% | +$4,955 | ||||||
2025-06-23 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | CEO | P - Purchase | $1.14 | +4,350 | 348,470 | +1% | +$4,946 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |